Clinical Trial Update: Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating flexible dosing of solifenacin in patients with frequent micturition with and without urgency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Asan Medical Center | Conditions: Urinary Bladder, Overactive, Overactive Bladder | Phase 4 | Status: COMPLETED